Cited 0 times in
Pembrolizumab with or without chemotherapy versus chemotherapy alone for patients with PD-L1-positive advanced gastric or gastroesophageal junction adenocarcinoma: Update from the phase 3 KEYNOTE-062 trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.